Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proarrhythmic responses during electrophysiologic testing.

A P Rae

    Cardiology Clinics
    |August 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Antiarrhythmic drugs can cause proarrhythmia, a dangerous side effect. This review examines its mechanisms, identification methods like electrophysiologic testing, and incidence with specific drugs.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diagnostic utility of cardiac magnetic resonance imaging in STEMI survivors after emergency PCI.

    International journal of cardiology·2013
    Same author

    Brugada-pattern ECG and cardiac arrest in cocaine toxicity: reading between the white lines.

    Heart (British Cardiac Society)·2010
    Same author

    Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.

    The American journal of cardiology·1998
    Same author

    Coronary artery spasm leading to life threatening arrhythmias.

    Heart (British Cardiac Society)·1998
    Same author

    Use of fax facility improves decision making regarding thrombolysis in acute myocardial infarction.

    Heart (British Cardiac Society)·1997
    Same author

    Role of endogenous opioids and catecholamines in vasovagal syncope.

    European heart journal·1996
    Same journal

    At the Edge of the Possible: A New Standard for Cardiovascular Critical Care.

    Cardiology clinics·2026
    Same journal

    End-of-Life Care in the Cardiovascular Intensive Care Unit.

    Cardiology clinics·2026
    Same journal

    Strategies to Reduce Failure to Rescue after Cardiac Surgery.

    Cardiology clinics·2026
    Same journal

    Embracing Enhanced Recovery After Cardiac Surgery Program.

    Cardiology clinics·2026
    Same journal

    Post-Heart Transplantation Intensive Care Unit Recovery: A Phase-Based Approach.

    Cardiology clinics·2026
    Same journal

    A Practical Guide to Intensive Care Unit Management after Left Ventricular Assist Device Implantation.

    Cardiology clinics·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Proarrhythmia is a life-threatening adverse effect associated with antiarrhythmic drug therapy.
    • Understanding the mechanisms and identification of proarrhythmia is crucial for patient safety.

    Purpose of the Study:

    • To discuss the underlying mechanisms of proarrhythmia.
    • To review methods for identifying proarrhythmia, including electrophysiologic testing.
    • To examine the incidence of proarrhythmia with various antiarrhythmic agents.

    Main Methods:

    • Literature review of mechanisms and identification approaches for proarrhythmia.
    • Analysis of the applicability and validity of electrophysiologic testing in diagnosing proarrhythmia.
    • Review of reported incidence rates of proarrhythmia for individual antiarrhythmic drugs.

    Related Experiment Videos

    Main Results:

    • Proarrhythmia presents a significant clinical challenge in antiarrhythmic drug use.
    • Electrophysiologic testing offers insights into proarrhythmia but requires careful interpretation of responses to programmed stimulation.
    • The incidence of proarrhythmia varies among different antiarrhythmic agents.

    Conclusions:

    • Further research into proarrhythmia mechanisms and improved diagnostic strategies are needed.
    • Clinical vigilance and appropriate use of electrophysiologic testing are essential for managing antiarrhythmic drug risks.
    • Individualized risk assessment is necessary when prescribing antiarrhythmic medications.